Advances in siRNA delivery approaches in cancer therapy: challenges and opportunities
Authors:
- 23 September 2023
- journal article
- review article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 50 (11) , 9529-9543
Abstract
Advancements in the clinical applications of small interfering RNA (siRNA) in cancer therapy have opened up new possibilities for precision medicine. siRNAs, as powerful genetic tools, have shown potential in targeting and suppressing the expression of specific genes associated with cancer progression. Their effectiveness has been further enhanced by incorporating them into nanoparticles, which protect siRNAs from degradation and enable targeted delivery. However, despite these promising developments, several challenges persist in the clinical translation of siRNA-based cancer therapy. This comprehensive review explores the progress and challenges associated with the clinical applications of siRNA in cancer therapy. This review highlights the use of siRNA-loaded nanoparticles as an effective delivery system for optimizing siRNA efficacy in various types of carcinomas and the potential of siRNA-based therapy as a genetic approach to overcome limitations associated with conventional chemotherapeutic agents, including severe drug toxicities and organ damage. Moreover, it emphasizes on the key challenges, including off-target effects, enzymatic degradation of siRNAs in serum, low tumor localization, stability issues, and rapid clearance from circulation that need to be addressed for successful clinical development of siRNA-based cancer therapy. Despite these challenges, the review identifies significant avenues for advancing siRNA technology from the laboratory to clinical settings. The ongoing progress in siRNA-loaded nanoparticles for cancer treatment demonstrates potential antitumor activities and safety profiles. By understanding the current state of siRNA-based therapy and addressing the existing challenges, we aim to pave the way for translating siRNA technology into effective oncologic clinics as an improved treatment options for cancer patients.Keywords
This publication has 108 references indexed in Scilit:
- Liposome: classification, preparation, and applicationsDiscover Nano, 2013
- Improving the Endosomal Escape of Cell-Penetrating Peptides and Their Cargos: Strategies and ChallengesPharmaceuticals, 2012
- Action and Reaction: The Biological Response to siRNA and Its Delivery VehiclesMolecular Therapy, 2012
- Elimination Pathways of Systemically Delivered siRNAMolecular Therapy, 2011
- Targeted Gene Silencing Using RGD-Labeled Chitosan NanoparticlesClinical Cancer Research, 2010
- Delivery of siRNA Therapeutics: Barriers and CarriersThe AAPS Journal, 2010
- Engineering RNA for Targeted siRNA Delivery and Medical ApplicationAdvanced Drug Delivery Reviews, 2010
- siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effectBMC Bioinformatics, 2009
- Nonviral Methods for siRNA DeliveryMolecular Pharmaceutics, 2008
- Strategies for silencing human disease using RNA interferenceNature Reviews Genetics, 2007